Nina Jackson Levin1, Anao Zhang2, David Reyes-Gastelum3, Debbie W Chen4, Ann S Hamilton5, Bradley Zebrack6, Megan R Haymart7. 1. School of Social Work and Department of Anthropology, University of Michigan, 1080 S. University Ave, Room B660, Ann Arbor, MI, 48109, USA. 2. School of Social Work, University of Michigan, 1080 S. University, Room 3704, Ann Arbor, MI, 48109, USA. 3. Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, North Campus Research Complex, 2800 Plymouth Rd. Bldg. 16, 400S-20, MI, 48109, Ann Arbor, USA. 4. Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Domino's Farms (Lobby C, Suite 1300), 24 Frank Lloyd Wright Drive, PO Box 451, Ann Arbor, MI, 48106, USA. 5. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001 N. Soto St., SSB318E, MC9239, Los Angeles, CA, 90089-9239, USA. 6. School of Social Work, University of Michigan, 1080 S. University, Room 2778, Ann Arbor, MI, 48109, USA. 7. Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Bldg 16, Rm 408E, Ann Arbor, MI, 48109, USA. meganhay@med.umich.edu.
Abstract
PURPOSE: The purpose of this study is to assess change in worry over time in Hispanic women with thyroid cancer. METHODS: Worry about recurrence, quality of life, family at risk, death, and harm from treatments was assessed in 273 Hispanic women with thyroid cancer diagnosed in 2014-2015. Subjects were recruited from Surveillance, Epidemiology, and End Results (SEER) Los Angeles. Participants were surveyed at two points in time (time 1: 2017-2018 and time 2: 2019). Multivariable logistic regression was used to determine correlates with high worry (somewhat, quite a bit, very much) versus low worry (not at all, a little) at time 2. RESULTS: For the five worry items, 20.1-39.6% had high worry at both time 1 and time 2. An additional 7.6-13.4% had low worry at time 1 that became high worry at time 2. In multivariable logistic regression controlling for age, recurrence status, education level, and number of complications or side effects symptoms, younger age (20-39) as compared to older (40-79) was associated with high worry about thyroid cancer recurrence (OR 2.16, 95% CI 1.12-4.17). History of recurrent or persistent disease was associated with high worry about harms from treatment (OR 2.94, 95% CI 1.29-6.67). Greater number of complications or side effects of symptoms was associated with more worry across all five items. CONCLUSIONS: Some Hispanic women with thyroid cancer have persistently high worry, with young adult Hispanic women vulnerable to worry about recurrence. IMPLICATIONS FOR CANCER SURVIVORS: Hispanic women with thyroid cancer may benefit from targeted psychosocial support during survivorship, with interventions informed by patient and cancer characteristics.
PURPOSE: The purpose of this study is to assess change in worry over time in Hispanic women with thyroid cancer. METHODS: Worry about recurrence, quality of life, family at risk, death, and harm from treatments was assessed in 273 Hispanic women with thyroid cancer diagnosed in 2014-2015. Subjects were recruited from Surveillance, Epidemiology, and End Results (SEER) Los Angeles. Participants were surveyed at two points in time (time 1: 2017-2018 and time 2: 2019). Multivariable logistic regression was used to determine correlates with high worry (somewhat, quite a bit, very much) versus low worry (not at all, a little) at time 2. RESULTS: For the five worry items, 20.1-39.6% had high worry at both time 1 and time 2. An additional 7.6-13.4% had low worry at time 1 that became high worry at time 2. In multivariable logistic regression controlling for age, recurrence status, education level, and number of complications or side effects symptoms, younger age (20-39) as compared to older (40-79) was associated with high worry about thyroid cancer recurrence (OR 2.16, 95% CI 1.12-4.17). History of recurrent or persistent disease was associated with high worry about harms from treatment (OR 2.94, 95% CI 1.29-6.67). Greater number of complications or side effects of symptoms was associated with more worry across all five items. CONCLUSIONS: Some Hispanic women with thyroid cancer have persistently high worry, with young adult Hispanic women vulnerable to worry about recurrence. IMPLICATIONS FOR CANCER SURVIVORS: Hispanic women with thyroid cancer may benefit from targeted psychosocial support during survivorship, with interventions informed by patient and cancer characteristics.
Authors: Maria Papaleontiou; David Reyes-Gastelum; Brittany L Gay; Kevin C Ward; Ann S Hamilton; Sarah T Hawley; Megan R Haymart Journal: Thyroid Date: 2019-07-25 Impact factor: 6.568
Authors: Bibi Hølge-Hazelton; Helle U Timm; Christian Graugaard; Kirsten A Boisen; Cecilie Dyg Sperling Journal: Support Care Cancer Date: 2016-06-28 Impact factor: 3.603
Authors: Lev D Bubis; Laura Davis; Alyson Mahar; Lisa Barbera; Qing Li; Lesley Moody; Paul Karanicolas; Rinku Sutradhar; Natalie G Coburn Journal: J Clin Oncol Date: 2018-03-01 Impact factor: 44.544
Authors: Kimberly D Miller; Ann Goding Sauer; Ana P Ortiz; Stacey A Fedewa; Paulo S Pinheiro; Guillermo Tortolero-Luna; Dinorah Martinez-Tyson; Ahmedin Jemal; Rebecca L Siegel Journal: CA Cancer J Clin Date: 2018-10-04 Impact factor: 508.702
Authors: Nancy K Janz; Christopher R Friese; Yun Li; John J Graff; Ann S Hamilton; Sarah T Hawley Journal: J Cancer Surviv Date: 2013-11-13 Impact factor: 4.442
Authors: Kevin J Kovatch; David Reyes-Gastelum; David T Hughes; Ann S Hamilton; Kevin C Ward; Megan R Haymart Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-09-01 Impact factor: 6.223
Authors: Joshua M Evron; David Reyes-Gastelum; Mousumi Banerjee; Laura D Scherer; Lauren P Wallner; Ann S Hamilton; Kevin C Ward; Sarah T Hawley; Brian J Zikmund-Fisher; Megan R Haymart Journal: J Clin Oncol Date: 2019-10-01 Impact factor: 50.717
Authors: Lauren P Wallner; David Reyes-Gastelum; Ann S Hamilton; Kevin C Ward; Sarah T Hawley; Megan R Haymart Journal: J Clin Oncol Date: 2019-07-08 Impact factor: 50.717
Authors: Maria Papaleontiou; Bradley Zebrack; David Reyes-Gastelum; Andrew J Rosko; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Megan R Haymart Journal: J Cancer Surviv Date: 2020-09-16 Impact factor: 4.062